JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

C5006 UK 1

Summary: inhibitor of topoisomerase II and hepatitis C viral replication

Soluble in DMSO;Soluble in dimethyl formamide
B6168 OICR-9429
3 Citation

Summary: Wdr5-MLL interaction antagonist

insoluble in EtOH; insoluble in H2O; ≥21.52 mg/mL
C3352 R-1 Methanandamide Phosphate

Summary: CB1 receptor agonist

≤15 mg/mL
C3564 2,3-Butanedione-2-monoxime

Summary: myosin ATPase inhibitor

≥5.25 mg/mL
C3986 Muraglitazar

Summary: dual agonist of PPARα and PPARγ

Soluble in DMSO
A4517 ZM 449829

Summary: JAK3 inhibitor

insoluble in H2O; insoluble in EtOH; ≥8.2 mg/mL
A5399 Iloperidone

Summary: Dopamine (D2) and serotonin (5HT2) receptor antagonist

≥21.32 mg/mL
A5786 Natamycin
1 Citation

Summary: Antifungal macrolide polyene

insoluble in EtOH; insoluble in H2O; ≥16.43 mg/mL
A8535 Tetraethylenepentamine 5HCl

Summary: polyamine catalyst for the bisulfite reaction of cytosine

insoluble in EtOH; insoluble in DMSO; ≥141.8 mg/mL
A8400 Clinafloxacin CI96 AM1091

Target: Topoisomerases

Summary: Topoisomerase inhibitor

insoluble in H2O; insoluble in EtOH; ≥3.66 mg/mL